Your browser doesn't support javascript.
loading
Ravulizumab 100 mg/mL formulation reduces infusion time and frequency, improving the patient and caregiver experience in the treatment of atypical haemolytic uraemic syndrome.
Dixon, Bradley P; Sabus, Ashley.
Affiliation
  • Dixon BP; Renal Section, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Sabus A; Children's Hospital Colorado, Aurora, Colorado, USA.
J Clin Pharm Ther ; 47(7): 1081-1087, 2022 Jul.
Article in En | MEDLINE | ID: mdl-35304755
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atypical Hemolytic Uremic Syndrome Limits: Humans Language: En Journal: J Clin Pharm Ther Journal subject: FARMACIA / TERAPEUTICA Year: 2022 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atypical Hemolytic Uremic Syndrome Limits: Humans Language: En Journal: J Clin Pharm Ther Journal subject: FARMACIA / TERAPEUTICA Year: 2022 Document type: Article Affiliation country: United States Country of publication: United kingdom